Assignee
FYFE MATTHEW COLIN THOR
GB·3 granted patents·11 pending applications·31 citations·filing 2004–2012
Top patents by PatentIndex Score
14 records- 0189US9006449B2Cyclopropylamine derivatives useful as LSD1 inhibitorsFYFE MATTHEW COLIN THOR·Filed 2011·Granted Apr 14, 2015·19 cites·26 claims
- 0274US8207147B2Heterocyclic derivatives as GPCR receptor agonistsFYFE MATTHEW COLIN THOR·Filed 2004·Granted Jun 26, 2012·10 cites·11 claims
- 0369US8193359B2G-protein coupled receptor agonistsFYFE MATTHEW COLIN THOR·Filed 2005·Granted Jun 5, 2012·2 cites·14 claims
- 0454US2014163041A1Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disordersFYFE MATTHEW COLIN THOR·Filed 2012·Application pending·0 cites
- 0548US2008293730A1Tricyclo Substituted AmidesFYFE MATTHEW COLIN THOR·Filed 2006·Application pending·0 cites
- 0647US2010048631A1Piperidine GPCR AgonistsFYFE MATTHEW COLIN THOR·Filed 2008·Application pending·0 cites
- 0747US2010286110A1Azetidinyl g-protein coupled receptor agonistsFYFE MATTHEW COLIN THOR·Filed 2008·Application pending·0 cites
- 0846US2010048632A1Piperidine GPCR AgonistsFYFE MATTHEW COLIN THOR·Filed 2008·Application pending·0 cites
- 0944US2009005391A1Tricyclo Substituted AmidesFYFE MATTHEW COLIN THOR·Filed 2006·Application pending·0 cites
- 1043US2009281076A1Azetidine Derivatives as G-Protein Coupled Receptor (GPR119) AgonistsFYFE MATTHEW COLIN THOR·Filed 2007·Application pending·0 cites
- 1143US2008293741A1Tricyclo Substituted Amides as Glucokinase ModulatorsFYFE MATTHEW COLIN THOR·Filed 2006·Application pending·0 cites
- 1239US2010048625A1Piperidine gpcr agonistsFYFE MATTHEW COLIN THOR·Filed 2008·Application pending·0 cites
- 1337US2010105732A1Piperidine gpcr agonistsFYFE MATTHEW COLIN THOR·Filed 2008·Application pending·0 cites
- 1436US2008312281A1G-Protein Coupled Receptor (Gpr116) Agonists and Use Thereof for Treating Obesity and DiabetesFYFE MATTHEW COLIN THOR·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →